Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improves outcomes (major amputation and survival) up a 5-year follow-up, but it is not known if in this length of time the survival curves, of clinical responders and non-responders, differ.

Long-term survival of patients with critical limb ischemia treated with iloprost: response rate and predictive criteria. A retrospective analysis of 102 patients

BERCHIOLLI, RAFFAELLA NICE
Co-primo
;
2016

Abstract

Critical limb ischemia (CLI) patients have poor long-term prognosis. We showed that iloprost improves outcomes (major amputation and survival) up a 5-year follow-up, but it is not known if in this length of time the survival curves, of clinical responders and non-responders, differ.
Melillo, E; Lucaccini, Elena; Berchiolli, RAFFAELLA NICE; Adami, Davide; Nuti, M; Dell'Omo, Giulia; Farina, A; Panigada, G; Roberts, A. T; Meini, S.
File in questo prodotto:
File Dimensione Formato  
Long term survival of patients with critical limb ischemia treated with iloprost response rate and predictive criteria. A retrospective analysis of 102 patients.pdf

accesso aperto

Tipologia: Versione finale editoriale
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 388.89 kB
Formato Adobe PDF
388.89 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/834810
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact